Search results
Results from the WOW.Com Content Network
In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
The following are key perspectives from the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (AF): The current guideline's classification of AF focuses on the stages of AF including the pre-detection period.
The 3 selected messages are focused on the new stages of atrial fibrillation (take-home message 1), the importance of early rhythm control (take-home message 5), and the use of catheter ablation as first-line therapy in select patients (take-home message 6).
The newest clinical guideline released by the ACC and the American Heart Association (AHA) provides new and updated recommendations for preventing and optimally managing atrial fibrillation (AFib).
Atrial Fibrillation: Guideline for Diagnosis and Management - American College of Cardiology. 75th Gala.
This guideline issues new recommendations for atrial fibrillation and thromboembolic risk assessment, anticoagulation, occlusion of the left atrial appendage, AFib catheter ablation, prevention of and risk modification for this patient population.
November 30, 2023—The American College of Cardiology (ACC) and American Heart Association (AHA) released updated recommendations for preventing and managing atrial fibrillation. The new guideline was developed in collaboration with and and endorsed by the American College of Clinical Pharmacy (ACCP) and the Heart Rhythm Society (HRS).